• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于开发含低剂量药物的即释固体制剂的有效技术:熔融沉积成型 3D 打印。

An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing.

机构信息

Department of Pharmaceutical Technology, Faculty of Pharmacy, Gazi University, 06330, Ankara, Turkey.

出版信息

Pharm Res. 2019 Jun 27;36(9):128. doi: 10.1007/s11095-019-2655-y.

DOI:10.1007/s11095-019-2655-y
PMID:31250313
Abstract

PURPOSE

Fabrication of immediate release (IR) tablet formulations with rapid release profile via fused deposition modeling 3D printing (FDM 3DP) is a challenge. The aims of this study were to prepare IR tablets with different dissolution profiles and to increase their in vitro dissolution rates by making physical modifications on them. Pramipexole was used as the model low-dose drug.

METHODS

Polymeric filaments were prepared with six different combinations of Eudragit EPO and poly(ethylene) oxide by hot melt extrusion and 3D tablets were produced using an FDM printer. Characterization studies for the filaments and tablets were carried out. The printability of the filaments was also evaluated using a novel mechanical characterization method. Tablet formulation with optimum dissolution profile was chosen and physical modifications (infill %, shape change and thickness) on this formulation were made.

RESULTS

Low-dose pramipexole loading filaments and 3D tablets were homogenously prepared. The printability of the filaments was related to their flexibility. With the physical modifications, the drug release completion time of the tablets reduced to 5 min.

CONCLUSIONS

The same rapid release profiles with conventional IR tablets can be reached by making only physical changes on 3D tablets without using any filling or disintegrating agents.

摘要

目的

通过熔融沉积成型 3D 打印(FDM 3DP)制造具有快速释放特征的即时释放(IR)片剂制剂是一项挑战。本研究的目的是制备具有不同溶解特征的 IR 片剂,并通过对其进行物理改性来提高其体外溶解速率。普拉克索被用作模型低剂量药物。

方法

通过热熔挤出法制备了六种不同组合的 Eudragit EPO 和聚氧化乙烯的聚合物长丝,并使用 FDM 打印机生产 3D 片剂。对长丝和片剂进行了表征研究。还使用新型机械特性表征方法评估了长丝的可打印性。选择具有最佳溶解特征的片剂配方,并对该配方进行物理改性(填充百分比、形状变化和厚度)。

结果

均匀地制备了低剂量普拉克索负载长丝和 3D 片剂。长丝的可打印性与其柔韧性有关。通过物理改性,片剂的药物释放完成时间缩短至 5 分钟。

结论

无需使用任何填充剂或崩解剂,仅通过对 3D 片剂进行物理改变,就可以获得与传统 IR 片剂相同的快速释放特征。

相似文献

1
An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing.一种用于开发含低剂量药物的即释固体制剂的有效技术:熔融沉积成型 3D 打印。
Pharm Res. 2019 Jun 27;36(9):128. doi: 10.1007/s11095-019-2655-y.
2
Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.熔融沉积建模的快速药物释放 3D 打印片剂的配方:用于药物释放、药物-聚合物混溶性和可印刷性筛选的聚合物。
J Pharm Sci. 2018 Jan;107(1):390-401. doi: 10.1016/j.xphs.2017.10.021. Epub 2017 Oct 21.
3
An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.一项关于使用聚合物共混物来改善通过熔融沉积建模(FDM)3D打印制备的药物固体分散体的可印刷性并调节其药物释放的研究。
Eur J Pharm Biopharm. 2016 Nov;108:111-125. doi: 10.1016/j.ejpb.2016.08.016. Epub 2016 Sep 2.
4
Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.熔融沉积成型 3D 打印方法的简化:一步直接粉末打印用于即时释放剂型生产的可行性。
Int J Pharm. 2020 Mar 30;578:119124. doi: 10.1016/j.ijpharm.2020.119124. Epub 2020 Feb 5.
5
A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.低温熔融沉积成型 3D 打印技术用于制造患者专用的即释片剂。
Pharm Res. 2016 Nov;33(11):2704-12. doi: 10.1007/s11095-016-1995-0. Epub 2016 Aug 9.
6
Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.重点关注工业相关性的速释(IR)3D打印口服剂型的开发。
Eur J Pharm Sci. 2020 Dec 1;155:105558. doi: 10.1016/j.ejps.2020.105558. Epub 2020 Sep 16.
7
The applicability of pharmaceutical polymeric blends for the fused deposition modelling (FDM) 3D technique: Material considerations-printability-process modulation, with consecutive effects on in vitro release, stability and degradation.药物聚合物共混物在熔融沉积成型(FDM)3D 技术中的适用性:材料考虑因素——可印刷性——工艺调节,对体外释放、稳定性和降解有连续影响。
Eur J Pharm Sci. 2019 Mar 1;129:110-123. doi: 10.1016/j.ejps.2018.12.019. Epub 2019 Jan 2.
8
3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.3D 打印制药口服固体制剂的熔融沉积法:使用增塑 HPMCAS 提高可印刷性。
Int J Pharm. 2022 Mar 25;616:121553. doi: 10.1016/j.ijpharm.2022.121553. Epub 2022 Feb 5.
9
3D printed extended release tablets for once daily use: An in vitro and in vivo evaluation study for a personalized solid dosage form.3D 打印的延长释放片剂,每日一次使用:一种个性化固体制剂的体外和体内评价研究。
Int J Pharm. 2021 Mar 1;596:120222. doi: 10.1016/j.ijpharm.2021.120222. Epub 2021 Jan 21.
10
Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.释放调节剂在熔融沉积成型(FDM)3D 打印片剂中调节药物释放的作用。
Int J Pharm. 2021 Mar 15;597:120315. doi: 10.1016/j.ijpharm.2021.120315. Epub 2021 Feb 1.

引用本文的文献

1
Concept and Evolution in 3D Printing for Excellence in Healthcare.用于卓越医疗保健的3D打印概念与发展
Curr Med Chem. 2025;32(5):831-879. doi: 10.2174/0109298673262300231129102520.
2
Potential Applications and Additive Manufacturing Technology-Based Considerations of Mesoporous Silica: A Review.介孔硅的潜在应用和基于增材制造技术的考虑因素:综述
AAPS PharmSciTech. 2023 Dec 21;25(1):6. doi: 10.1208/s12249-023-02720-7.
3
Diverse Applications of Three-Dimensional Printing in Biomedical Engineering: A Review.三维打印在生物医学工程中的多样应用:综述

本文引用的文献

1
The Use of 3D Printed Molds to Cast Tablets with a Designed Disintegration Profile.使用 3D 打印模具浇铸具有设计崩解特性的片剂。
AAPS PharmSciTech. 2019 Feb 26;20(3):127. doi: 10.1208/s12249-019-1341-z.
2
Extrusion 3D Printing of Paracetamol Tablets from a Single Formulation with Tunable Release Profiles Through Control of Tablet Geometry.挤出式 3D 打印单配方对乙酰氨基酚片剂及其通过控制片剂几何形状实现的释药轮廓可调。
AAPS PharmSciTech. 2018 Nov;19(8):3403-3413. doi: 10.1208/s12249-018-1107-z. Epub 2018 Aug 10.
3
Industrial Development of a 3D-Printed Nutraceutical Delivery Platform in the Form of a Multicompartment HPC Capsule.
3D Print Addit Manuf. 2023 Oct 1;10(5):1140-1163. doi: 10.1089/3dp.2022.0281. Epub 2023 Oct 10.
4
3D-printed dosage forms for oral administration: a review.3D 打印口服给药剂型:综述。
Drug Deliv Transl Res. 2024 Feb;14(2):312-328. doi: 10.1007/s13346-023-01414-8. Epub 2023 Aug 24.
5
Challenges, current status and emerging strategies in the development of rapidly dissolving FDM 3D-printed tablets: An overview and commentary.快速溶解的熔融沉积成型3D打印片剂开发中的挑战、现状及新兴策略:综述与评论
ADMET DMPK. 2023 Jan 1;11(1):33-55. doi: 10.5599/admet.1622. eCollection 2023.
6
Investigation on the use of fused deposition modeling for the production of IR dosage forms containing Timapiprant.关于使用熔融沉积成型法生产含替马普仑的红外剂型的研究。
Int J Pharm X. 2022 Dec 24;5:100152. doi: 10.1016/j.ijpx.2022.100152. eCollection 2023 Dec.
7
3D printing of pharmaceuticals: approach from bench scale to commercial development.药物的3D打印:从实验室规模到商业开发的路径
Futur J Pharm Sci. 2022;8(1):48. doi: 10.1186/s43094-022-00439-z. Epub 2022 Nov 26.
8
Hot-Melt Extrusion of the Thermo-Sensitive Peptidomimetic Drug Enalapril Maleate.马来酸依那普利热敏感拟肽药物的热熔挤出
Pharmaceutics. 2022 Sep 30;14(10):2091. doi: 10.3390/pharmaceutics14102091.
9
3D Printed Mini-Floating-Polypill for Parkinson's Disease: Combination of Levodopa, Benserazide, and Pramipexole in Various Dosing for Personalized Therapy.用于帕金森病的3D打印微型漂浮复方药丸:左旋多巴、苄丝肼和普拉克索不同剂量组合用于个性化治疗
Pharmaceutics. 2022 Apr 25;14(5):931. doi: 10.3390/pharmaceutics14050931.
10
3D Printing in Solid Dosage Forms and Organ-on-Chip Applications.3D 打印在固体制剂和器官芯片应用中的应用。
Biosensors (Basel). 2022 Mar 22;12(4):186. doi: 10.3390/bios12040186.
以多腔室 HPC 胶囊形式的 3D 打印营养药物输送平台的工业开发。
AAPS PharmSciTech. 2018 Nov;19(8):3343-3354. doi: 10.1208/s12249-018-1029-9. Epub 2018 Jun 5.
4
Reshaping drug development using 3D printing.利用 3D 打印重塑药物研发。
Drug Discov Today. 2018 Aug;23(8):1547-1555. doi: 10.1016/j.drudis.2018.05.025. Epub 2018 May 24.
5
Immediate Release 3D-Printed Tablets Produced Via Fused Deposition Modeling of a Thermo-Sensitive Drug.通过热熔沉积成型技术直接压片制备热敏药物的 3D 打印片剂
Pharm Res. 2018 Apr 20;35(6):124. doi: 10.1007/s11095-018-2405-6.
6
A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery.一种 3D 打印双层口腔固体制剂,结合了用于延长释放的二甲双胍和用于即刻药物递送的格列美脲。
Eur J Pharm Sci. 2018 Jul 30;120:40-52. doi: 10.1016/j.ejps.2018.04.020. Epub 2018 Apr 17.
7
Tablet fragmentation without a disintegrant: A novel design approach for accelerating disintegration and drug release from 3D printed cellulosic tablets.无崩解剂的片剂碎片化:一种从 3D 打印纤维素片剂中加速崩解和药物释放的新型设计方法。
Eur J Pharm Sci. 2018 Jun 15;118:191-199. doi: 10.1016/j.ejps.2018.03.019. Epub 2018 Mar 17.
8
On demand manufacturing of patient-specific liquid capsules via co-ordinated 3D printing and liquid dispensing.按需制造患者特异性液体胶囊的方法:通过协调的 3D 打印和液体分配。
Eur J Pharm Sci. 2018 Jun 15;118:134-143. doi: 10.1016/j.ejps.2018.03.010. Epub 2018 Mar 11.
9
Establishment of inherent stability of pramipexole and development of validated stability indicating LC-UV and LC-MS method.普拉克索内在稳定性的确立以及经验证的稳定性指示液相色谱-紫外和液相色谱-质谱方法的开发。
J Pharm Anal. 2013 Apr;3(2):109-117. doi: 10.1016/j.jpha.2012.07.011. Epub 2012 Aug 17.
10
Channelled tablets: An innovative approach to accelerating drug release from 3D printed tablets.通道片剂:一种创新方法,可加速 3D 打印片剂的药物释放。
J Control Release. 2018 Jan 10;269:355-363. doi: 10.1016/j.jconrel.2017.11.022. Epub 2017 Nov 13.